SNMMI Live Meetings - Faculty Guidelines

SNMMI is comprised of diverse professionals in the field of nuclear medicine and molecular imaging and therefore holds specific guidelines for our faculty/speaker presentations. As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), SNMMI must ensure that all CME programs meet all ACCME Core Accreditation Criteria and Standards for Integrity and Independence in Accredited Continuing Education, while maintaining the highest standards and expectations of its audience. Below are lists of faculty/speaker guidelines to assist you in developing the highest quality educational content and materials. These guidelines also ensure compliance to the SNMMI’s CME Conflicts of Interest and Separation of Education Activities and Commercial Promotion CME Policies.

Guidelines
1) Presentations must be free of commercial bias for or against any product.

2) Presentations that are concerned with commercial products must present objective information about those products, based on scientific methods generally accepted in the medical community. Information presented must conform to the generally accepted standards of experimental design, data collection and analysis.
a. The preponderance of data presented from clinical trials should be from peer-reviewed publications.
b. Material presented from trial results must include information on study design, subject selection and participation/compliance, therapeutic agents administered including source/dosage, adverse effects encountered, funding source, etc.
c. Faculty must offer a balanced presentation of all available trial data that is pertinent to the topic.

3) The content of slides and reference materials are the ultimate responsibility of the faculty selected by SNMMI. Material shall not, by their content or format, advance the specific proprietary interests of a commercial supporter.
a. Slides cannot include commercial company and product logos.
b. The preponderance of slides included in the presentation should reflect original thoughts and organization of the speaker.
c. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed, the speaker must disclose that the product is not labeled for the use under discussion or that the product is still investigational.
d. It is the responsibility of the faculty presenter to obtain written permission for print inclusion of material that is under copyright protection or when appropriate, provide the proper acknowledge/citation of where material was obtained.

4) Presentations must give a balanced view of therapeutic options. Faculty use of generic names will contribute to this impartiality. If trade names are used, those of several companies should be used rather than only that of a single supporting company.

5) SNMMI may distribute protected PDF files of PowerPoint presentations on the SNMMI web site with appropriate attribution to all speakers. All speakers retain copyright ownership of their presentations. The Course Speaker hereby represents and warrants: (1) that he or she either owns and holds the copyright to the materials or to the best of his or her knowledge and belief be entitled to copyright protection were an application to be submitted, or has obtained necessary release from the copyright holder; (2) that he or she has the authority to grant this nonexclusive license; and (3) that SNMMI’s exercise of its rights hereunder will not infringe upon any other person’s or entity’s copyrights or other proprietary rights.

6) SNMMI may record presentations in audio and/or visual form. SNMMI will be the sole copyright owner of the recording and can distribute and sell it. If a speaker’s presentation is recorded, SNMMI will provide the speaker one complimentary copy of the recording.

7) As a provider accredited by the ACCME and ACPE, the Society of Nuclear Medicine and Molecular Imaging must ensure that all CE activities are independent and free of commercial bias. Everyone in a position to control the content of a CE activity - planning committee members, organizers, moderators, faculty/speakers/presenters, authors, and staff must disclose ALL financial relationships with any commercial interest/ineligible company occurring within the past 24 months. A commercial interest/ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

NOTE:

• There is no minimum financial threshold; individuals must disclose ALL financial relationships, regardless of the amount, with commercial interests/ineligible companies.
• Individuals must disclose regardless of their view of the relevance of the relationship to the education.
• Financial relationships include the roles of employee, consultant, stockholder / investment interest, member of speakers’ bureau, researcher with grants or research support, and other roles. 
• SNMMI will disqualify any individual who refuses to disclose relevant financial relationships.
• If you have questions, please contact the SNMMI Accreditation Specialist at Education@SNMMI.org.